XML 65 R40.htm IDEA: XBRL DOCUMENT v3.22.1

Presentation and Preparation of the Consolidated Financial Statements and Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure Of Presentation And Preparation Of Consolidated Financial Statements And Significant Accounting Policies [Line Items]

Schedule of Exchange Rate of Currencies

The following is the detail of the exchange rates of the main currencies used by the Group compared to the USD in the year ended December 31, 2021 and 2020:

		Average rate								Year-end spot rate
		2021				2020				Dec 31, 2021				Dec 31, 2020
Argentina (ARS/USD)			94.9				71.9				102.6				84.1
Brazil (BRL/USD)			5.4				4.6				5.6				5.2
Chile (CLP/USD)			758.5				730.0				850.3				711.2
Colombia (COP/USD)			3,741.8				3,354.8				3,981.2				3,432.5
Ecuador (USD/USD)			1.0				1.0				1.0				1.0
Egypt (EGP/USD)			15.7				15.8				15.8				15.7
India (IRN/USD)			72.2				72.2				74.3				73.1
Israel (NIS/USD)			3.1				3.3				3.0				3.2
Malta (EUR/USD)			0.8				0.8				0.8				0.8
Mexico (MXN/USD)			20.5				19.4				20.3				19.9
Morocco (MAD/USD)			9.2				9.2				9.2				8.9
Panama (USD/USD)			1.0				1.0				1.0				1.0
Peru (PEN/USD)			4.0				3.5				3.9				3.6
Uruguay (UYU/USD)			44.7				39.8				43.6				42.3

Summary of Depreciation Is Calculated on a Straight-Line Basis Over the Estimated Useful Lives

The assets’ residual values and useful lives are reviewed at the end of each reporting period, and adjusted on a prospective basis, if appropriate. Depreciation is calculated on a straight-line basis over the estimated useful lives of the asset, as follows:

Computer Equipment 3 years

Building Improvements 10 years

Summary of Options Granted Under the Plan

Set out below are summaries of options granted under the plan:

		2021								2020
		Average								Average
		exercise price								exercise price
		per share								per share
		option				Number of				option				Number of
		(U.S. Dollars)				options and RSUs				(U.S. Dollars)				options
At the beginning of the year			1.22				17,361,000				1.22				406,500
Granted during the year			3.69				2,371,345				2.17				16,954,500
Exercised during the year			2.03				(15,685,000	)			—				—
Forfeited during the year			4.15				(15,000	)			—				—
At the end of the year			1.16				4,032,345				2.15				17,361,000
Vested and exercisable at the end of the year			3.54				486,750				2.02				15,685,000

Summary of Share Options Outstanding

Share options outstanding at the end of the year have the following expiry dates and exercise prices:

Grant date		Vesting period		Expiry date		Exercise price (U.S. Dollars per A Share)				Share options and RSUs December 31, 2021				Share options and RSUs December 31, 2020
August 1st, 2018		3 years		August 1st, 2021			0.74				90,500				271,500
October 1st, 2019		3 years		October 1st, 2022			2.18				90,000				135,000
January 31st, 2020		Less than 1 year		December 31st, 2024			2.04				—				15,459,000
August 24th, 2020		5 years		August 24th, 2025			3.30				835,000				835,000
November 15th, 2020		4 years		November 15th, 2024			4.15				135,000				135,000
November 23rd, 2020		5 years		November 23rd, 2025			3.88				525,500				525,500
January 1st, 2021		5 years		January 1st, 2026			3.88				210,000				—
March 1st, 2021		1 year		March 1st, 2022			0.002			**5,500					—
March 2nd, 2021		5 years		March 2nd, 2026			7.44				10,000				—
March 11th, 2021		5 years		March 11th, 2026			0.002			**1,031,000					—
March 11th, 2021		5 years		March 11th, 2026			7.44				36,000				—
March 12nd, 2021		5 years		March 12nd, 2026			7.44				7,000				—
March 15th, 2021		5 years		March 15th, 2026			7.44				7,500				—
March 29th, 2021		5 years		March 29th, 2026			7.44				10,000				—
May 11th, 2021		5 years		May 11th, 2026			7.44				927,500				—
May 11th, 2021		3 years		May 11th, 2024			0.002			**22,500					—
May 18th, 2021		5 years		May 18th, 2026			16.17				10,000				—
December 9th, 2021		5 years		December 9th, 2026			0.002			**79,345					—
Total											4,032,345				17,361,000
Weighted average remaining contractual life of restricted share units and share options outstanding at end of the year										4.24 years				4.02 years

* Retroactively adjusted to reflect the effect of the stock split (Note 1).

** It corresponds to Restricted Share Units ("RSUs") granted.

Summary of the Warrants Granted

Set out below is a summary of the warrants granted:

		2021								2020
		Average								Average
		exercise price								exercise price
		per share								per share
		warrant				Number of				warrant				Number of
		(U.S. Dollars)				warrants				(U.S. Dollars)				warrants
As at January 1			0.57				17,345,000				0.57				17,345,000
Granted during the year			—				—				—				—
Exercised during the year			0.57				(2,131,413	)			—				—
As at December 31			0.57				15,213,587				0.57				17,345,000
Vested and exercisable at December 31			0.57				15,213,587				0.57				17,345,000

X

- Definition

Disclosure of depreciation is calculated on a straight-line basis over the estimated useful lives.

+ References

No definition available.

+ Details

Name:	dlo_DisclosureOfDepreciationIsCalculatedOnAStraightLineBasisOverTheEstimatedUsefulLivesExplanatory
Namespace Prefix:	dlo_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of presentation and preparation of consolidated financial statements and significant accounting policies.

+ References

No definition available.

+ Details

Name:	dlo_DisclosureOfPresentationAndPreparationOfConsolidatedFinancialStatementsAndSignificantAccountingPoliciesLineItems
Namespace Prefix:	dlo_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of summary warrants granted.

+ References

No definition available.

+ Details

Name:	dlo_DisclosureOfSummaryWarrantsGrantedExplanatory
Namespace Prefix:	dlo_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for the effect of changes in foreign exchange rates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 21
-IssueDate 2021-01-01
-Section Disclosure
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2021-01-01
-Paragraph 45
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2021-01-01
-Paragraph 45
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration